Skip to main content

Latest Market News — Page 115

Page 115 · 30 stories scored 7+ · newest 6:38 AM ET · How scores work

Fri, Oct 2323 stories
8SPCXSpace Exploration Technologies Corp.SpaceX Accelerates 80,000-Site U.S. Wireless Buildout; Telecoms SlideProduct & regulatory · Dow Jones Newswires▲ PositivePro7ZLABZai Lab LtdZoci-Atezolizumab Doublet Hits 81.8% Response Rate in First-Line SCLCProduct & regulatory · BusinessWire▲ Positive8TNGXTango Therapeutics, Inc.82% Response Rate in Refractory Pancreatic Cancer; Phase 3 Set for 1H27Product & regulatory · Wiseek News▲ PositivePro8MKTXMarketAxess Holdings Inc.Credit Take-Rate Slides 9% as MarketAxess Posts Mixed Q3; ICE Deal Clears HSREarnings & guidance · Wiseek News● NeutralPro7GRCThe Gorman-Rupp CompanyGorman-Rupp Posts 3Q EPS of 86 CentsEarnings & guidance · Dow Jones Newswires▲ Positive7FCNCAFirst Citizens BancShares IncFirst Citizens Posts Q3 2026 Results, Adds New Buyback AuthorizationEarnings & guidance · Dow Jones Newswires● Neutral7ALVAUTOLIV INCAutoliv Guides 2026 to Flat Organic Sales, ~10.5% Adjusted MarginEarnings & guidance · Dow Jones Newswires● Neutral8ZYMEZymeworks Inc.Zymeworks Licenses DLL3 T Cell Engager ZW209 to Roche With $55M UpfrontM&A & partnerships · GlobeNewswire▲ PositivePro7FLGFlagstar Bank, National AssociationFlagstar Posts Thin 3Q EPS of 1 Cent as Shares Sit Near 52-Week LowEarnings & guidance · Dow Jones Newswires▼ Negative8RNGRingCentral, Inc.RingCentral Lifts 2026 Outlook After Q3 Beat; Shares Jump 16% PremarketEarnings & guidance · Seeking Alpha▲ PositivePro8PHATPhathom Pharmaceuticals, Inc.Generic Rival Sues FDA to Break VOQUEZNA Exclusivity Running to 2032Legal & risk · Wiseek News▼ NegativePro7VCYTVERACYTE, INC.Decipher Predicts Abiraterone Benefit in Very High-Risk Prostate Cancer, STAMPEDE Data ShowProduct & regulatory · GlobeNewswire▲ Positive7ALNYALNYLAM PHARMACEUTICALS, INC.Brezosiran Cuts Huntington's Protein Up to 83% in Early TrialProduct & regulatory · Wiseek News▲ Positive8ORICOric Pharmaceuticals, Inc.Enozertinib Hits 84% ORR in 1L EGFR Atypical NSCLC; Phase 3 Set for 1H 2027Product & regulatory · GlobeNewswire▲ PositivePro7METAMeta Platforms, Inc.Meta's AI Buildout Turns Cash-Negative as It Eyes Hundreds of Billions in New FundingFinancing · Wiseek News▼ Negative7TSLATesla, Inc.Tesla-SpaceX Merger Committees Formed as $16.8B Terafab Chip Plant ConfirmedM&A & partnerships · Wiseek News● Neutral7DGXQuest Diagnostics IncorporatedQ3 Beat and Raised Guidance Overshadowed by Cyber Incident at QuestEarnings & guidance · Wiseek News● Neutral7TSCOTractor Supply CompanyTractor Supply Reaffirms 2026 Outlook After 5.1% Q3 Sales GrowthEarnings & guidance · Wiseek News● Neutral7CMCSAComcast CorporationComcast Q3: Peacock Profits, But Free Cash Flow Drops 14.8% and Buybacks Stay FrozenEarnings & guidance · Wiseek News▼ Negative7JNJJohnson & JohnsonSmith & Nephew Talks to Combine With J&J Orthopaedics Unit Collapse Over CEO RoleM&A & partnerships · Reuters● Neutral7ZLABZai Lab LtdZai Lab Raises $250M in Private PlacementFinancing · Seeking Alpha▼ Negative9LNAILunai Bioworks Inc.Lunai Bioworks to Voluntarily Delist From Nasdaq After Equity FailureGovernance · Seeking Alpha▼ NegativePro8SDXAYSodexoSodexo Beats Organic Growth Guidance but Profit Margin Halves to 3.4%Earnings & guidance · Dow Jones Newswires● NeutralPro
Thu, Oct 227 stories
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.